Login / Signup

Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in Sweden.

Hanna GyllenstenAndrius KavaliunasChantelle MurleyKristina AlexandersonJan HillertPetter TinghögEmilie Friberg
Published in: Multiple sclerosis journal - experimental, translational and clinical (2019)
After initial high indirect costs for sick leave, people with RRMS had higher drug costs compared to people with PPMS. Cost drivers during SPMS initially followed the pattern in the RRMS population, but were replaced by indirect costs for disability pension.
Keyphrases
  • multiple sclerosis